NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 139 filers reported holding NXSTAGE MEDICAL INC in Q2 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,241,000 | +4.6% | 238,118 | -0.3% | 0.01% | 0.0% |
| Q3 2016 | $5,968,000 | +16.4% | 238,833 | +1.0% | 0.01% | +16.7% |
| Q2 2016 | $5,129,000 | +58.2% | 236,580 | +9.3% | 0.01% | +50.0% |
| Q1 2016 | $3,243,000 | -30.4% | 216,374 | +1.7% | 0.00% | -33.3% |
| Q4 2015 | $4,662,000 | +39.5% | 212,796 | +0.5% | 0.01% | +20.0% |
| Q3 2015 | $3,341,000 | +8.1% | 211,832 | -2.1% | 0.01% | +25.0% |
| Q2 2015 | $3,090,000 | +5.0% | 216,327 | +27.2% | 0.00% | 0.0% |
| Q1 2015 | $2,943,000 | -1.5% | 170,118 | +2.1% | 0.00% | 0.0% |
| Q4 2014 | $2,988,000 | +35.0% | 166,630 | -1.2% | 0.00% | +33.3% |
| Q3 2014 | $2,214,000 | -8.1% | 168,658 | +0.6% | 0.00% | 0.0% |
| Q2 2014 | $2,409,000 | +14.3% | 167,674 | +1.4% | 0.00% | 0.0% |
| Q1 2014 | $2,107,000 | +28.5% | 165,379 | +0.9% | 0.00% | +50.0% |
| Q4 2013 | $1,640,000 | -26.3% | 163,971 | -3.0% | 0.00% | -50.0% |
| Q3 2013 | $2,225,000 | -1.0% | 169,071 | +7.4% | 0.00% | 0.0% |
| Q2 2013 | $2,247,000 | – | 157,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
| DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
| KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
| Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
| Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
| GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
| Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
| Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |